ARTLifeLine: Assisted Reproduction Technology (ART) Family Health and Development Trajectory Cohort (ARTLL)

NCT ID: NCT06786871

Last Updated: 2025-01-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

100000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-20

Study Completion Date

2043-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to study the health status of infertile couples and their offspring using assisted reproductive technologies. The main questions it aims to answer are:

1. On the basis of the assisted reproduction birth cohort and related research established by the team in the early stage, further expand the construction of the "tracking cohort of familial health and development using assisted reproduction", combine emerging technologies such as cross-database linking and integration, multi-omics sequencing and classical cohort research design, and carry out long-term longitudinal follow-up across generations, covering the whole life cycle and health in multi-dimension.
2. Build a disease risk prediction model for pregnant women and children with assisted reproduction.
3. Delineate the growth curve and neurobehavioral development trajectory of assisted reproductive offspring at different stages.
4. Evaluate the adolescent fertility potential and risk factors of assisted reproductive offspring.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Recent Research Objectives (Within Five Years):

Build a risk prediction model for reproductive women and children in assisted reproduction, and identify potential molecular markers with high predictive value to provide epidemiological evidence clues for further basic mechanism research.

Analyze the health status of natural conception versus assisted reproduction pregnant women and children, growth and developmental curves of fetuses during pregnancy, and early neurobehavioral development levels of children after birth.
2. Medium to Long-Term Research Objectives (Future Research Directions of the Cohort):

Systematically evaluate the long-term effects of infertility and assisted reproductive treatments on the physiological, psychological, individual, and family development of parents and offspring.

Collaborate and share data with other domestic and international health cohorts or databases related to assisted reproduction, to compare and analyze the long-term safety of various assisted reproductive technologies on the health of infertile couples and their offspring.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Reproductive Techniques, Assisted Family Cohort Studies Development, Infant Reproductive Issues

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Couples who have had or plan IVF fertility treatment and their offsprings

Have performed or plan to undergo IVF fertility treatment; Paper or electronic medical records during fertility treatment are available; Obtain informed consent from the research subject or guardian of the minor

IVF treatment

Intervention Type PROCEDURE

Methods or procedures for the in vitro processing of human oocytes, sperm, or embryos for fertility purposes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IVF treatment

Methods or procedures for the in vitro processing of human oocytes, sperm, or embryos for fertility purposes

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

(1) Previous or planned IVF treatment; (2) paper or electronic medical records during fertility treatment are available; (3) Obtain informed consent from the research subject or guardian of the minor.

Exclusion Criteria

(1) Other assisted reproductive treatment techniques that exclude in vitro fertilization, including guided intercourse, ovulation induction, artificial insemination, etc.; (2) refusal of enrollment; (3) withdraw or abort the study at any time and for any reason.
Minimum Eligible Age

0 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking University Third Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jie Qiao, PhD

Role: STUDY_CHAIR

Peking University Third Hospital

Rong Li, PhD

Role: STUDY_DIRECTOR

Peking University Third Hospital

Wei Yuan, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Tongyan Han, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Liying Yan, PhD

Role: STUDY_DIRECTOR

Peking University Third Hospital

Yuanyuan Wang, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Rui / Yang, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Xiaohui / Zhu, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Lian / Chen, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Meihua / Piao, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Yunpu / Cui, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Yanan / Tang, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Chunling / Huang, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Chunmei / Zhang, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Linlin / Wang, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Ningning / Pan, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Huifeng Shi, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Tianchen / Wu, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Wanning / Qiu, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Jinfang / Yuan, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Hui / Zhang, MD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Qingqing Wang

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Meng Qin

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Ying Kuo

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Wenxi Zhang

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Shuo Guan

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Siming Jiang

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Fei Kong

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Tian Tian, PhD

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Lixue Chen

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Yu Fu

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Fang Liu

Role: PRINCIPAL_INVESTIGATOR

Peking University Third Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking University Third Hospital, Beijing, China

Beijing, Beijing Municipality, China

Site Status

Peking University Third Hospital

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

M2023095

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ReceptIVFity & Immunology in ART
NCT06709976 ENROLLING_BY_INVITATION